Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2018 (2018), Article ID 1864962, 6 pages
https://doi.org/10.1155/2018/1864962
Case Report

Recurrent Syncope, a Clue in Amyloid Cardiomyopathy

Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA

Correspondence should be addressed to Ricardo J. Pagán

Received 26 October 2017; Revised 8 December 2017; Accepted 26 December 2017; Published 28 January 2018

Academic Editor: Grigrios Korosoglou

Copyright © 2018 Julian A. Marin-Acevedo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Merlini and V. Bellotti, “Molecular mechanisms of amyloidosis,” New England Journal of Medicine, vol. 349, no. 6, pp. 583–596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Falk, K. M. Alexander, R. Liao, and S. Dorbala, “AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy,” Journal of the American College of Cardiology, vol. 68, no. 12, pp. 1323–1341, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Bejar, P. C. Colombo, F. Latif, and M. Yuzefpolskaya, “Infiltrative cardiomyopathies,” Clinical Medicine Insights: Cardiology, vol. 9, no. 2, pp. 29–38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Chamarthi, S. W. Dubrey, K. Cha, M. Skinner, and R. H. Falk, “Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis,” American Journal of Cardiology, vol. 80, no. 9, pp. 1242–1245, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Gertz, M. D. Benson, P. J. Dyck et al., “Diagnosis, prognosis, and therapy of transthyretin amyloidosis,” Journal of the American College of Cardiology, vol. 66, no. 21, pp. 2451–2466, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. I. Su, J.-P. Tsai, S.-H. Chang, and C.-H. Su, “Cardiac amyloidosis presenting as recurrent syncope,” Acta Cardiologica Sinica, vol. 30, no. 1, pp. 86–89, 2014. View at Google Scholar
  7. S. W. Dubrey, K. Cha, J. Anderson et al., “The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement,” QJM, vol. 91, no. 2, pp. 141–157, 1998. View at Publisher · View at Google Scholar
  8. M. Linhart, C. Troatz, G. Nickenig, and D. Skowasch, “Cardiac amyloidosis presenting as recurrent syncope,” Revista Española de Cardiología, vol. 64, no. 9, pp. 840-841, 2011. View at Publisher · View at Google Scholar
  9. G. Finocchiaro, B. Pinamonti, M. Merlo et al., “Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up,” Journal of Cardiovascular Medicine, vol. 14, no. 4, pp. 281–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Benson and N. R. Dasgupta, “Amyloid cardiomyopathy,” Journal of the American College of Cardiology, vol. 68, no. 1, pp. 25–28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Buss, M. Emami, D. Mereles et al., “Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers,” Journal of the American College of Cardiology, vol. 60, no. 12, pp. 1067–1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Bellavia, P. A. Pellikka, A. Dispenzieri et al., “Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study,” European Heart Journal-Cardiovascular Imaging, vol. 13, no. 8, pp. 680–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kuruvilla, N. Adenaw, A. B. Katwal, M. J. Lipinski, C. M. Kramer, and M. Salerno, “Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis,” Circulation: Cardiovascular Imaging, vol. 7, no. 2, pp. 250–258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. I. S. Syed, J. F. Glockner, D. Feng et al., “Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis,” JACC: Cardiovascular Imaging, vol. 3, no. 2, pp. 155–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Maurer, P. Elliott, R. Comenzo, M. Semigran, and C. Rapezzi, “Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis,” Circulation, vol. 135, no. 14, pp. 1357–1377, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Haaf, P. Garg, D. R. Messroghli, D. A. Broadbent, J. P. Greenwood, and S. Plein, “Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review,” Journal of Cardiovascular Magnetic Resonance, vol. 18, no. 1, p. 89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. D. Gillmore, M. S. Maurer, R. H. Falk et al., “Nonbiopsy diagnosis of cardiac transthyretin amyloidosis,” Circulation, vol. 133, no. 24, pp. 2404–2412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Bokhari, R. Shahzad, A. Castaño, and M. S. Maurer, “Nuclear imaging modalities for cardiac amyloidosis,” Journal of Nuclear Cardiology, vol. 21, no. 1, pp. 175–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Gertz, A. Dispenzieri, and T. Sher, “Pathophysiology and treatment of cardiac amyloidosis,” Nature Reviews Cardiology, vol. 12, no. 2, pp. 91–102, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Grogan, A. Dispenzieri, and M. A. Gertz, “Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response,” Heart, vol. 103, no. 14, pp. 1065–1072, 2017. View at Publisher · View at Google Scholar
  21. M. A. Gertz, R. Comenzo, R. H. Falk et al., “Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis,” American Journal of Hematology, vol. 79, no. 4, pp. 319–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Palladini, S. Sachchithanantham, P. Milani et al., “A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis,” Blood, vol. 126, no. 5, pp. 612–615, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Mahmood, G. Palladini, V. Sanchorawala, and A. Wechalekar, “Update on treatment of light chain amyloidosis,” Haematologica, vol. 99, no. 2, pp. 209–221, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Roy, “Autologous stem cell transplant for Al amyloidosis,” Bone Marrow Research, vol. 2012, Article ID 238961, 5 pages, 2012. View at Publisher · View at Google Scholar
  25. A. N. Rosenbaum and B. S. Edwards, “Current indications, strategies, and outcomes with cardiac transplantation for cardiac amyloidosis and sarcoidosis,” Current Opinion in Organ Transplantation, vol. 20, no. 5, pp. 584–592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Mehra, C. E. Canter, M. M. Hannan et al., “The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update,” Journal of Heart and Lung Transplantation, vol. 35, no. 1, pp. 1–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. R. H. Sayed, D. Rogers, F. Khan et al., “A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis,” European Heart Journal, vol. 36, no. 18, pp. 1098–1105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Hamon, V. Algalarrondo, E. Gandjbakhch et al., “Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis,” International Journal of Cardiology, vol. 222, pp. 562–568, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Tsukanov and E. D. Fabbro, “Palliative care and symptom management in amyloidosis: a review,” Current Problems in Cancer, vol. 40, no. 5-6, pp. 220–228, 2016. View at Publisher · View at Google Scholar · View at Scopus